Anthera Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
21
- Stock Symbol
-
ANTH
- Investments
-
1
Anthera Pharmaceuticals General Information
Description
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.
Contact Information
Corporate Office
- 700 Milam
- Suite 1300
- Houston, TX 77002
- United States
Corporate Office
- 700 Milam
- Suite 1300
- Houston, TX 77002
- United States
Anthera Pharmaceuticals Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 11.2K |
Anthera Pharmaceuticals Financials Summary
As of 31-Mar-2018, Anthera Pharmaceuticals has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Mar-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 | FY 2015 31-Dec-2015 |
|---|---|---|---|---|
| EV | 5,610 | 17,109 | (1,648) | 129,260 |
| Revenue | 0 | 0 | 145 | 3,185 |
| EBITDA | (22,994) | (26,593) | (55,257) | (34,935) |
| Net Income | (23,391) | (26,874) | (55,523) | (35,220) |
| Total Assets | 8,811 | 3,673 | 23,471 | 48,125 |
| Total Debt | 0 | 0 |
Anthera Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Anthera Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Anthera Pharmaceuticals Comparisons
Industry
Financing
Details
Anthera Pharmaceuticals Competitors (94)
One of Anthera Pharmaceuticals’s 94 competitors is Dermavant Sciences, a Formerly PE-Backed company based in Long Beach, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dermavant Sciences | Formerly PE-Backed | Long Beach, CA | ||||
| Arrowhead Pharmaceuticals | Corporation | Pasadena, CA | ||||
| Alaunos Therapeutics | Formerly VC-backed | Fort Lauderdale, FL | ||||
| Moderna | Formerly VC-backed | Cambridge, MA | ||||
| Incyte | Formerly VC-backed | Wilmington, DE |
Anthera Pharmaceuticals Patents
Anthera Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170369551-A1 | Methods of treating iga nephropathy and henoch-schonlein purpura nephritis using a b-cell activating factor (baff) inhibitor | Inactive | 24-Jun-2016 | ||
| WO-2017223534-A2 | Methods of treating iga nephropathy and henoch-schönlein purpura nephritis using a b-cell activating factor (baff) inhibitor | Inactive | 24-Jun-2016 | ||
| WO-2017223534-A3 | Methods of treating iga nephropathy and henoch-schönlein purpura nephritis using a b-cell activating factor (baff) inhibitor | Inactive | 24-Jun-2016 | ||
| US-20110301202-A1 | Spla2 inhibitor conjugate compounds and methods of use | Inactive | 04-Jun-2010 | ||
| WO-2011153433-A1 | Spla2 inhibitor conjugate compounds and methods of use | Inactive | 04-Jun-2010 | A61K31/4439 |
Anthera Pharmaceuticals Signals
Anthera Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Anthera Pharmaceuticals Investments (1)
Anthera Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Eli Lilly and Company (Sollpura). The deal was made on 14-Jul-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Eli Lilly and Company (Sollpura) | 14-Jul-2014 | Corporate Asset Purchase | Buildings and Property |
Anthera Pharmaceuticals FAQs
-
When was Anthera Pharmaceuticals founded?
Anthera Pharmaceuticals was founded in 2004.
-
Where is Anthera Pharmaceuticals headquartered?
Anthera Pharmaceuticals is headquartered in Houston, TX.
-
What is the size of Anthera Pharmaceuticals?
Anthera Pharmaceuticals has 21 total employees.
-
What industry is Anthera Pharmaceuticals in?
Anthera Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Anthera Pharmaceuticals a private or public company?
Anthera Pharmaceuticals is a Public company.
-
What is Anthera Pharmaceuticals’s stock symbol?
The ticker symbol for Anthera Pharmaceuticals is ANTH.
-
Who are Anthera Pharmaceuticals’s competitors?
Dermavant Sciences, Arrowhead Pharmaceuticals, Alaunos Therapeutics, Moderna, and Incyte are some of the 94 competitors of Anthera Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process